Crystal structure determination
Crystals of MADH from T. versutus have been obtained as described
previously (Vellieux et al., 1986), except that crystals were grown and stored
at 4°C. A single crystal of excellent quality was obtained from virtually
each hanging drop experiment. The space group is P3121, with a = b =
129.8 A, c = 104.3 A. The asymmetric unit contains one HL dimer with
aMr of 60 400. The Vm is exceptionally high, 4.2 A3/dalton, which means
that the fraction of the volume of the unit cell occupied by solvent is - 70%
(Matthews, 1968). The enzyme as it is isolated contains the co-factor in
its semiquinone form (De Beer et al., 1980).
X-ray diffraction data for the native enzyme and three heavy atom
derivatives were collected on 1-1.5° oscillation photographs using the X-31
beam line of the DESY-EMBL outstation in Hamburg, except for the low
resolution native data which was collected using Cu Kcx radiation from an
Elliot GX6 rotating anode generator. Data processing was carried out using
established film processing programs (Schwager et al., 1975; Rossmann,
1979). Derivative data sets were scaled to native data using a local scaling
procedure (Matthews and Czerwinski, 1975). Initial heavy atom substitution
models were obtained from difference Patterson maps using vector search
programs (Argos and Rossman, 1974), and were completed by difference
Fourier methods. The final heavy atom model is composed of three sites
for the uranyl acetate derivative, three sites for the platinium iodate derivative
and five sites for the second platinium derivative. Phase refinement and
phase calculation were carried out using the program PHARE (written by
Dr G.Bricogne), with anomalous scattering information used for each
derivative.
From these data, first a multiple isomorphous replacement (Green et al.,
1954) electron density distribution at 4.5 A resolution was calculated. This
clearly showed the outline of the molecule and the large solvent regions
in the crystals. The resolution was then gradually extended to 3.5 A in 45
solvent flattening cycles. From this point onwards, the crystal structure
determination went as follows.
(1) An improved high resolution native dataset became available and the
MIRAS phasing procedure was repeated. Phases could be calculated
to 2.5 A resolution with much improved statistics (Tables III and IV).
(2) A 2.5 A resolution density map was obtained, and subjected to 60
cycles of solvent flattening and phase extension from 3.5 to 2.5 A
resolution by a modification of the method by Frederick et al. (1984).
(3) In the resulting map, the polypeptide chain in the large subunit region
could be traced. A model for this subunit, where side chains were
assigned solely on the basis of the electron density, was refined using
molecular dynamics procedures (Bringer et al., 1987; Fujinaga et al.,
1989). The R factor at this stage was 36%. The resulting partial model
phases (Rice, 1981) were combined with 'solvent flattening phases'
to produce a new 2.25 A electron density map.
(4) The polypeptide chain in the small subunit of MADH was partially
traced in this map and an incomplete model, made up of the large
subunit plus segments of the small subunit, was refined. The R factor
decreased to 30%. Again, phase combination was carried out to produce
an improved electron density map.
(5) In this density a revised model of the entire small subunit of MADH
could now be built, and six disulphide bridges plus the co-factor
unambiguously located. In this step an 'X-ray sequence' for the small
subunit was deduced. The resulting model was subjected to a few cycles
of molecular dynamics refinement. After phase combination a final
2.25-A resolution electron density map was obtained, and used to study
the novel type of co-factor.
Crystals of phenylhydrazine-derivatized enzyme were obtained by, first,
oxidizing the free radical form of the co-factor by soaking in a solution
of Wurster's blue. Afterwards, these oxidized crystals were transferred to
a solution of the phenylhydrazine. The 3.0 A inhibited enzyme dataset was
collected in 10' frames on a FAST area detector system (Arndt, 1982)
using Cu Ka radiation from an Elliot GX2 1 rotating anode X-ray generator
and processed using the MADNES program package (Pflugrath and
Messerschmidt, 1986).
8 trang |
Chia sẻ: honghp95 | Lượt xem: 516 | Lượt tải: 0
Bạn đang xem nội dung tài liệu Structure of quinoprotein methylamine dehydrogenase at 0 2.25 A resolution, để tải tài liệu về máy bạn click vào nút DOWNLOAD ở trên
The EMBO Journal vol.8 no.8 pp.2171 -2178, 1989
Structure of quinoprotein methylamine dehydrogenase at
0
2.25 A resolution
F.M.D.Vellieux, F.Huitema, H.Groendijk,
K.H.Kalk, J.Frank Jzn.', J.A.Jongejan1,
J.A.Duinel, K.Petratos2, J.Drenth and
W.G.J.Hol
Laboratory of Chemical Physics, University of Groningen, Nijenborgh
16, 9747 AG Groningen, 'Department of Microbiology and
Enzymology, Delft University of Technology, Julianalaan 67, 2628 BC
Delft, The Netherlands and 2EMBL Outstation, c/o DESY,
Notkestrasse 85, 2000 Hamburg 52, FRG
Communicated by W.G.J.Hol
The three-dimensional structure of quinoprotein methyl-
amine dehydrogenase from Thiobacillus versutus has been
determined at 2.25 A resolution by a combination of
multiple isomorphous replacement, phase extension by
solvent flattening and partial structure phasing using
molecular dynamics refinement. In the resulting map,
the polypeptide chain for both subunits could be followed
and an X-ray sequence was established. The tetrameric
enzyme, made up of two heavy (H) and two light (L)
subunits, is a flat parallelepiped with overall dimensions
of -76 x 61 x 45 A. The H subunit, comprising 370
residues, is made up of two distinct segments: the first
31 residues form an extension which embraces one of the
L subunits; the remaining residues are found in a
disc-shaped domain. This domain is formed by a circular
arrangement of seven topologically identical four-
stranded antiparallel f-sheets, with - 7-fold symmetry.
In spite of distinct differences, this arrangement is
reminiscent of the structure found in influenza virus
neuraminidase. The L subunit consists of 121 residues,
out of which 53 form a fl-sheet scaffold of a central
three-stranded antiparallel sheet flanked by two shorter
two-stranded antiparallel sheets. The remaining residues
are found in segments of irregular structure. This subunit
is stabilized by six disulphide bridges, plus two covalent
bridges involving the quinone co-factor and residues 57
and 107 of this subunit. The active site is located in a
channel at the interface region between the H and L
subunits, and the electron density in this part of the
molecule suggests that the co-factor of this enzyme is not
pyrrolo quinoline quinone (PQQ) itself, but might be
instead a precursor of PQQ.
Key words: methylamine dehydrogenase/quinoproteins/
protein crystallography/enzymes/pro-PQQ
Introduction
Oxidoreductases require the presence of co-factors to be
enzymatically active. The structures of enzymes containing,
e.g. FAD, FMN, NAD and NADP as co-enzymes (see,
e.g. Rossman et al., 1975; Filman et al., 1982; Lindquist
and Branden, 1985; Karplus and Schulz, 1987; Schreuder
et al., 1988) are well characterized, but no structures
have been reported so far of enzymes from which the
recently discovered co-factor pyrrolo quinoline quinone
(PQQ) has been obtained. In most of these PQQ-containing
enzymes (which are collectively called 'quinoproteins'), the
co-factor becomes detached from the protein on denaturation
and apo-quinoproteins are effectively reconstituted with
PQQ (Duine and Jongejan, 1989). Most interesting is the
recent finding that PQQ is also the co-factor of several
mammalian enzymes, including bovine plasma amine
oxidase (Lobenstein-Verbeek et al., 1984), bovine adrenal
dopamine f-hydroxylase (Van der Meer et al., 1988) and
human placental lysyl oxidase (Van der Meer and Duine,
1986). In these cases, the co-factor is covalently bound to
the protein and PQQ is detected in the form of a hydrazone
after the enzyme has reacted with a hydrazine followed by
pronase treatment. Although this indicates that the co-factor
is attached via amide or ester bonds, no three-dimensional
(3D) structure of a quinoprotein is available so that it is
unknown how its co-factor is bound and which residues are
involved. Methylamine dehydrogenase (EC 1.4.99.3) is an
attractive model to study this aspect since it has similarity
with the mammalian quinoprotein amine oxidases (EC
1.4.3.6) (Lobenstein-Verbeek et al., 1984).
Methylamine dehydrogenase catalyses the following
reaction:
CH3NH3+ + H20 HCHO + NH4+ + 2H+ + 2e-
A blue copper protein, amicyanin, acts as electron acceptor
for the dehydrogenase. All methylamine dehydrogenases
investigated so far have a similar composition, consisting
of two large, or heavy (H), and two small, or light (L),
subunits, each small subunit containing a covalently bound
co-factor. Sequence studies showed that this co-factor is
attached at two sites to the protein chain (Ishii et al., 1983).
Based on ESR and ENDOR spectroscopy the co-factor
was proposed to be PQQ or a PQQ-like compound (De
Beer et al., 1980). Recently, the latter suggestion received
further attention when a PQQ-like structure was proposed,
which lacked the carboxylic acid groups of PQQ, and was
attached to the protein with Cys thio ether and Ser oxygen
ether linkages (McIntire and Stults, 1986). However,
application of the hydrazine method (Van der Meer et al.,
1987) produced a hydrazone with the chromatographic and
spectral properties of the hydrazone of authentic PQQ.
Moreover, the hydrazone could be converted into PQQ, as
judged from chromatographic and spectral data as well as
activity in a bioassay. Therefore, it was concluded that the
co-factor in methylamine dehydrogenase is PQQ, attached
to the small subunit with pronase scissable bonds (Van der
Meer et al., 1987).
Methylamine dehydrogenase (or MADH) from the
methylotrophic bacterium Thiobacillus versutus has a mol.
2171©cIRL Press
F.M.D.Vellieux et al.
Fig. 1. The structure of T. versutus methylamine dehydrogenase. Stereo view of the H2L2 tetramer along the crystallographic axis relating two HL
dimers. The large, or H, subunits are shown in green; the small, or L, subunits in blue. Note how the N terminus extension of one large subunit
'embraces' the small subunit.
Fig. 2. View of the small subunit in stereo with the ,B-strands in blue, the loops in green and the six disulphide bridges bridges in yellow. The
model for the quinone co-factor is shown in red.
wt of - 121 000, with the L and H subunits having a M,
of 12 900 and 47 500 respectively (Vellieux et al., 1986).
We describe here the X-ray structure of this quinoprotein.
In the latest 2.25-A electron density map obtained, the
polypeptide chains for both L and H subunits could be
followed, an 'X-ray sequence' established, six disulphide
bridges determined and the position of the co-factor
elucidated.
Results
Molecular structure and subunit - subunit interactions
The tetrameric enzyme is a flat parallelepiped with overall
dimensions of - 76 x 61 x 45 A (Figure 1). The molecule
can most easily be described as a dimer of HL dimers. The
MADH tetramer is held together by extensive interactions
taking place between subunits. It is interesting to note that
no direct interactions occur between the two L subunits
within the tetramer, as had earlier been predicted from
cross-linking experiments (Matsumoto and Tobari, 1978b).
The interactions which do occur can be divided into three
classes. First, the less extensive interactions (in terms of the
surface area involved) are found between the two large
subunits, symmetrically across the molecular 2-fold axis
(Figure 1). These H-H' interactions are quite limited in
number since they only involve two residues from one loop
in contact with two residues of the other, H', subunit. The
second type of interaction is between the H subunit and
the L' subunit belonging to a different H'L' dimer. These
H - L' contacts mainly involve the interaction between the
N-terminal arm of the H subunit, including the terminal
helix, which 'embraces' the L' subunit (Figure 1). Finally,
the most extensive interactions occur between H and L
subunits within one HL dimer. These interactions involve
many aromatic residues which might be important, since the
active site cavity is found near this interface.
Folding pattern of the small, co-factor binding,
subunit
In our present model the L subunit consists of 121 amino
acid residues. This subunit contains a total of seven fl-strands
connected by several stretches of rather irregular structure.
The central element of this subunit is a long three-stranded
antiparallel ,8-sheet with the usual left-handed twist formed
by strands 4, 5 and 7 (Figures 2 and 5). This main structural
element is flanked at the 'back' by two shorter two-stranded
antiparallel sheets formed by strands 2 and 3, and by strands
1 and 6. Thus, the subunit is formed by a scaffold of 53
2172
3D structure of quinoprotein methylamine dehydrogenase
Fig. 3. A stereo view of the main body of the large subunit, with the seven 'W' (3-sheet motifs in different colours. The direction of view is along
the pseudo-7-fold axis.
Fig. 4. Electron density of the quinone co-factor in methylamine dehydrogenase with the postulated 'pro-PQQ' shown. This is the density of a
2.25 A map with combined phases obtained from the refined partial model of both subunits using an 'X-ray sequence'. The atoms of the co-factor
were not included in refinement or phase calculations so that an entirely unbiased view of the density is obtained. The two covalent links with the
polypeptide chain are visible in the density, but have not been modelled.
residues in a fl-sheet conformation, while the remaining
residues are found in loops and segments of random coil.
The structure is further maintained by numerous covalent
linkages. The L subunit is expected to contain a total of 12
cysteine residues, as deduced from amino acid composition
studies (F.Huitema, J.A.Duine and J.J.Beintema, unpub-
lished results). In the final electron density map, six peaks
of high density were found to interconnect the polypeptide
chain. These were interpreted as the six disulphide bridges
shown in Figure 5, with their location being compatible with
that of the 12 cysteines found in the sequence of the L subunit
of MADH from Pseudomonas AMI (Ishii et al., 1983).
These disulphide bridges are probably important for stabil-
izing the 3D structure of this subunit, as is observed from
denaturation experiments (Matsumoto and Tobari, 1978a).
Two other covalent bridges are found, involving the co-factor
and residues 57 and 107 of this subunit, which will be
discussed below in detail.
Topology of the large subunit
This subunit contains 370 amino acid residues in our current
model. This is less than expected for a subunit of Mr
47 500 (Vellieux et al., 1986) which could be due to mobility
or disorder of one or both chain termini leading to weak
density in the map, or it could be the result of an overestimate
of the mol. wt, or both. The large subunit consists of two
distinct segments. The first 31 residues of the subunit form
the extended arm which is part of the H - L' contact region
mentioned above. This N-terminal extension comprises a 4.5
turn a-helix connected to a stretch of 15 residues in an
extended conformation. This stretch is fully accessible to
solvent but nevertheless very well defined in our electron
density map, where it is seen to form an additional fl-strand,
running alongside strand 3 of the L' subunit. The remaining
339 residues are found in a compact, disc-shaped domain.
This main body of the subunit is formed by seven four-
stranded antiparallel f-sheets, each with exactly the same
2173
F.M.D.Vellieux et al.
VAL ASP PRO ARG ALAI| LYS TRP GLN PRO GLN ASP ASN ASP ILE bLN ALAI| LYS ASP IIKY II RP I ARL HIS 61Y JU ILE SCS l
CYS 38 |
ARSLY SER| VAL ASN [TYR LY YS61- S
S-S\ GLY 38L3YS CYS S 86
LEU~~~~~~~~~~~~~~~~~~~~~~~~~~~ESSAR86 7a4 l
ALA_CYSs--CCs 10877717
ASP THR
GLYS ASP29
LEU ARS4b-S SER
ASN I TYR CGYL
90 CYS 23
IGLU AL RA
GLY CYSY297VAL
GLU
TYR
ASNSNS-S
LYSASPALAASN ~ ~ ~ ~ FROASPILIE 0 CY PE SLY SLY
CYS78
SLYLALPSROSFSER
120~~~~~~~~~6
LSAPALA ASF8 APROL ILE CYSPH GLGY
127 OX 108 19
S -
YS8 36
Fig. 5. The X-ray sequence of the small subunit depicted together with representations of the disuiphide bridges and the residues involved in covalent
links to the quinone co-factor. The boxes arranged in zig-zag represent the residues found in 3-sheets regions. A total of seven [3-strands are found
in the subunit, which comprise the following residues: 30-35 (strand 1); 40-42 (strand 2); 45-47 (strand 3); 50-64 (strand 4); 68-78 (strand 5):
86-90 (strand 6); 118- 127 (strand 7). These strands form three [3i-sheets in the following manner: sheet A by strands 1 and 6; sheet B by strands 2
and 3, and the central sheet C by strands 4, 5 and 7. Note that the X-ray sequence begins at residue 7, since we did not find any electron density
corresponding to the first six residues in this N-terminal region, when compared with recent sequence data obtained by F.Huitema, J.A.Duine and
J.J.Beintema (unpublished results).
'W' topology (Figures 3 and 6). These seven fl-sheets are
named WI -W7. The four individual strands of each sheet,
or W, are named A- D; A being the strand nearest to the
centre of the subunit, D running along the surface of the
subunit (Figure 6). Connections between consecutive ,B-sheets
are made up by long loops linking strand D of one f-sheet
with strand A of the next fl-sheet. The last sheet, W7, con-
tains both termini, with the N-terminal extension entering
the main body of the subunit as strand B and strand A formed
by the C-terminal segment of the subunit (Figure 6). This
is the only deviation from the otherwise identical topology
seen in all other Ws.
Internal pseudo-symmetry of the H subunit
The circularly symmetrical arrangement of seven nearly
identical units, described above as Ws, is clearly one of the
most striking features of the MADH structure. If the seven
repeated units are viewed from the 'top' of the disc, it
becomes immediately obvious that the structure contains
a pseudo 7-fold axis of symmetry, whose direction is
approximately parallel to that of the A strands of each W
(Figure 3). This unexpected observation is confirmed by pair-
wise superpositions which were carried out for these W
motifs. The et carbons in the fl-strand regions of all Ws are
found to superimpose very well with r.m.s. deviations rang-
2174
3D structure of quinoprotein methylamine dehydrogenase
W2
W5
W7
WI
Fig. 6. Schematic diagram of topology and numbering of sheets and
strands in the large subunit of MADH.
Table I. Comparison of 13-sheets (Ws) in the large subunit of
methylamine dehydrogenase
WI W2 W3 W4 W5 W6 W7
WI - 1.1 2.2 1.4 1.0 1.2 1.3
W2 47.5 - 2.0 2.3 1.1 1.0 1.6
W3 98.6 44.9 - 1.8 2.2 2.2 2.2
W4 150.3 103.2 48.2 - 1.5 1.4 1.4
W5 208.2 162.4 119.2 58.6 - 1.1 1.0
W6 269.3 224.8 178.4 120.2 59.9 - 1.0
W7 315.2 270.8 224.7 167.1 108.3 48.9 -
7-fold (308.6) (257.1) (205.7) (154.3) (102.9) (51.4) -
Results of superimposing the seven 13-sheets of the large subunit of
MADH onto each other. The upper half of the matrix contains the
r.m.s. deviations in A. The left half gives the rotation angle required
to obtain the best superposition of two sheets. From the variation of
this rotation angle along the diagonals, an impression of the deviation
from perfect 7-fold symmetry is obtained. The lower line gives the
rotation angles corresponding with an ideal 7-fold axis, given in the
order 6/7 x 3600, 5/7 x 360°, etc., for easy comparison with the
numbers in the line immediately above.
ing from 1.0 to 2.3 A (Table I).
When the results of this superposition ofWs are analysed
more carefully (Table II) a rather precise direction of the
internal pseudo-symmetry axis can be found. However, the
rotation angles thus obtained show considerable deviations
from ideal 7-fold symmetry. Nevertheless, this remarkable
structural repetition strongly suggests that the large subunit
of MADH evolved from an ancestor made up of seven fully
identical ,B-sheets.
Relationship of the H subunit to neuraminidase
MADH is the second example of a protein structure with
a circular arrangement of topologically identical four-
stranded antiparallel 3-sheets. This uncommon motif had
earlier been recognized as the main structural element of the
influenza virus neuraminidase (Varghese et al., 1983), which
Table II. Angular relationship of Ws in H-MADH
First Second xa Pb aC r.m.s. Number of
3-sheet $-sheet ( (0) (0) dev. equivalent
(A) atoms
WI W4 150.3 258.8 100.2 1.4 26
W2 W5 162.4 258.6 102.7 1.1 27
W3 W6 178.4 259.1 104.6 2.2 25
W4 W7 167.1 263.8 102.2 1.4 27
W5 WI 151.8 259.6 97.7 1.0 30
W6 W2 135.2 257.4 100.0 1.0 28
W7 W3 135.3 256.2 105.5 2.3 26
Average value (0) 154.4 259.1 101.8
SD (0) 16.0 2.4 2.7
aThe polar angles x, p and V describe a rotation as defined in
Rossman and Blow (1963).
Superposition of pairs of $-sheets yielding a surprisingly similar
direction of the rotation axis as shown by the small standard deviations
of p and 1. However the angle of rotation about this axis, x, varies
considerably. A basic feature to note is the observation that W3 and
W6 can be superimposed onto each other by a pseudo 2-fold rather
than by a rotation of 4/7 x 3600, or 154.3°. Also note that the
average rotation angle x in this table differs only 0.10 from that of an
ideal 7-fold, but that the standard deviation is very large.
catalyses the hydrolysis of the a-ketosidic bond between
sialic acid and an adjacent sugar residue. When pair-wise
superpositions are carried out after careful selection of
equivalent residues in the fl-strands of both structures (with
coordinates kindly made available by Dr P.Colman, CSIRO,
Australia) the r.m.s. deviation between equivalent a carbon
atoms is found to be quite small, i.e. between 0.6 and 2.8 A.
It must be noted, however, that despite the great similarity
of the W motifs, the two subunits are nevertheless distinctly
different in several respects. First, whereas the H subunit
of MADH has a quite regular packing of f-sheets, that of
neuraminidase is not so regular, therefore giving a more
irregularly shaped subunit. Thus exact superposition of one
complete neuraminidase subunit on top of H-MADH is not
feasible-at least not with r.m.s. deviations < 4 A. A second
difference between the two structures is found in the sheet
containing both chain termini, which is W7 in our notation.
In H-MADH the A-strand of W7 is provided by the C
terminus and strands B, C and D by the N terminus of the
subunit. In neuraminidase, strands A, B and C are provided
by the C terminus and only strand D by the N terminus.
A third difference is the fifth folding unit, which is a 'perfect'
W motif in H-MADH, but appears to be an irregularly
shaped loop region in neuraminidase. In spite of these
differences, the intriguing possibility exists that both enzymes
evolved from a common ancestor, which consisted of seven
identical W folding units. A complex series of gene
duplication and fusion events, followed by divergence, then
led to the observed differences in W5 and W7. Once
sequence information becomes available, this postulated
evolutionary relationship can be studied at the level of
primary structure.
The active site region and the structure of the co-
factor
The active site of MADH is situated in a channel, or
cavity, found at the interface region between the large and
2175
F.M.D.Vellieux et al.
a
H02
CYS 108
\ PHE109 S-S
I \ 5 CYS 78
l48S-~~AfAl - 1. I
SY
t ,9,.
I
Fig. 7. (a) Structure and atomic numbering of pyrroloquinoline
quinone (PQQ). (b) Schematic drawing of a possible interpretation of
the electron density shown in Figure 4 (see text also). It should be
clear that several features of this model need independent confirmation.
In particular the nature of the group providing two covalent links with
the polypeptide chain can obviously not be derived with any certainty
from an electron density map calculated with phases from a model
where an 'X-ray sequence' had to be used. These links are therefore
indicated with dotted lines. The density for the 2-carboxylate group is
weak and, hence, this group is also shown with dotted lines.
small subunit of each HL dimer. The presence of numerous
hydrophobic side chains seen in this cavity suggests that the
reaction will proceed in a very hydrophobic, and possibly
water depleted environment. The density for the co-factor
is connected at two positions to the polypeptide chain of the
small subunit (Figure 4).
The two attachment sites are at residues 57 and 107 in
our X-ray sequence. These connections are very similar to
those found for the co-factor of the Pseudomonas AM1
enzyme, as obtained from amino acid sequence studies (Ishii
et al., 1983). Surprisingly, only two of the PQQ rings fit
nicely into the density, whereas the third one, the pyridine
ring, could not be inserted convincingly. The 3.0 A Fo-Fc
difference Fourier map, calculated for the phenylhydrazine-
derivatized enzyme, showed extra density at the presumed
5 carbonyl position [numbering of atoms is analogous to that
of PQQ (Figure 7a)], thereby defining the location of this
carbonyl group of the co-factor. Careful model building
based on these findings suggested that the six-membered
pyridine ring of PQQ is not present as such in the native
MADH co-factor. In fact, both the 2.25-A native map, and
the 3.0-A map for the hydrazine treated enzyme suggest that
this third ring is not closed. Both covalent linkages to the
polypeptide chain are seen to occur via this part of the
co-factor, for which the 7-carboxylate group density is well
defined.
Taking into account that the bacterial biosynthetic pathway
of free PQQ presumes the addition of a glutamic acid to
an indole structure derived from tyrosine (Houck et al.,
1988; Van Kleef and Duine, 1988), and application of the
hydrazine method to the enzyme suggests that all structural
elements from PQQ should be present (Van der Meer et
al., 1987), the following hypothesis on the structure of
the co-factor in MADH (Figure 7b) seems plausible: the
co-factor has a quinone indole structure, derived from
tyrosine, to which a glutamic acid moiety is attached by a
C9a-&Cy linkage. The latter moiety is attached to the protein
chain at two positions: (i) to residue 57 of the small subunit
via the -y-carboxyl group of the glutamate, and (ii) to residue
107 of the subunit via the a-amino group of the glutamate.
The PQQ-phenylhydrazone which is identified during
characterization of the co-factor of MADH (Van der Meer
et al., 1987) is then generated by ring closure to form the
third, missing ring of PQQ during this procedure. Closure
of the third ring will proceed rather easily, as found in routes
of chemical synthesis of PQQ (Buchi et al., 1985) where
this reaction occurs under mild conditions.
At present the electron density map does not reveal the
precise nature of the residues binding the co-factor, but it
is clear that they are rather small. In view of the fact that
at least one of the bonds connecting the co-factor to the
protein appears to be pronase-sensitive (Van der Meer et
al., 1987), peptide, ester or thioester bonds are good
candidates. This implies that residue 107 might be an aspartic
acid forming a peptide bond with the a-amino group of the
glutamate moiety. Residue 57 could be a serine, threonine
or cysteine involved in an ester of thioester bond with the
,y-carboxylate group. However, modelling these covalent
linkages in the current electron density map did not prove
to be straightforward. Clearly, further crystallographic,
sequencing and chemical studies are required to fully reveal
the secrets of this co-factor.
Since the co-factor as found in MADH could be similar
to one of the last intermediates in the biosynthesis route of
free PQQ, we propose that it should be named 'pro-PQQ'.
Conclusions
The X-ray structure of T.versutus MADH gives, for the
first time, a view on the active site of a quinoprotein, with
its co-factor covalently bound to two protein side chains.
Available evidence indicates that this co-factor is not PQQ
itself, but rather pro-PQQ, containing both the quinone
indole moiety, plus a protein bound glutamate residue. This
observation agrees with the reported differences observed
in the spectral properties of MADH and of other quinoprotein
dehydrogenases where PQQ becomes detached as such upon
denaturation (Kenney and McIntire, 1983; Husain et al.,
2176
3D structure of quinoprotein methylamine dehydrogenase
Table III. Data statistics, results of heavy atom parameter refinement:
data collection and processing
Data set No. of No. of Rmergea
observations unique
reflections
Native 1 (film) 125 245 32 211 0.058 (on F)
Native 2 (film) 317 421 49 688 0.103 (on I)
K2PtL6 (film) 126 660 33 427 0.048 (on F)
Pt(en)C12 (film) 91 914 24 533 0.086 (on F)
U02(C2H302)2 (film) 127 066 27 988 0.098 (on I)
phenylhydrazine-inhibited (FAST) 44 065 18 819 0.079 (on F)
N
aRmr
_E lFi -Flmerge=
E Fi
Table IV. Data statistics, results of heavy atom parameter refinement:
MIRAS phase calculation to 2.5 A
Resolution (A) 13.33 8.24 5.96 4.76 3.84 3.26 2.86 2.50 Total
0.81 0.78 0.77 0.70 0.62 0.60 0.59 0.50 0.75
K2PtI6
F,/Eja 2.01 2.17 2.35 1.68 1.19 0.78 0.63 1.00 1.23
Rc,11lisa 0.58 0.47 0.51 0.64 0.79 0.92 0.96 0.74 0.71
Pt(en)CI2
Fc/Eja 2.51 2.36 2.14 1.38 1.02 0.83 0.75 - 1.22
Rcullis 0.45 0.53 0.54 0.61 0.88 0.93 1.29 - 0.69
U02(C2H302)2
Fc/Eja 2.55 2.21 2.39 1.83 1.38 1.54 1.73 1.42 1.68
Rcullisa 0.30 0.48 0.52 0.58 0.80 0.73 0.69 0.54 0.63
aR = E FPH FP + FH(calo for centric reflections only.
ElIFPHI -IFPI
1987; Frank et al., 1988). This point has also been discussed
by Hartmann and Klinman (1988).
The mechanism by which the co-factor is incorporated into
the enzyme remains most intriguing. One might speculate
that MADH itself is involved in several of the steps leading
to the formation of its functional co-factor. In this context
it is interesting to refer to enzymes containing a side chain
of the protein's constituent amino acids as a co-factor, in
particular those using the free radical of tyrosine for catalytic
conversions (Prince, 1988). If these residues are in fact
primitive co-factors, pro-PQQ could be considered as an
intermediate in the evolution of tyrosine to PQQ.
Another startling finding in MADH was the discovery
of a 7-fold circular arrangement of fl-sheets, which
constitute the main body of its large subunit. This, together
with the obvious structural similarity to influenza virus
neuraminidase, suggests that both structures might have
evolved from the same ancestor. It is quite remarkable to
observe such a close topological relationship between
enzymes with entirely different functions present in
methylotrophic bacteria and in the influenza virus.
Materials and methods
Crystal structure determination
Crystals of MADH from T. versutus have been obtained as described
previously (Vellieux et al., 1986), except that crystals were grown and stored
at 4°C. A single crystal of excellent quality was obtained from virtually
each hanging drop experiment. The space group is P3121, with a = b =
129.8 A, c = 104.3 A. The asymmetric unit contains one HL dimer with
aMr of 60 400. The Vm is exceptionally high, 4.2 A3/dalton, which means
that the fraction of the volume of the unit cell occupied by solvent is - 70%
(Matthews, 1968). The enzyme as it is isolated contains the co-factor in
its semiquinone form (De Beer et al., 1980).
X-ray diffraction data for the native enzyme and three heavy atom
derivatives were collected on 1-1.5° oscillation photographs using the X-31
beam line of the DESY-EMBL outstation in Hamburg, except for the low
resolution native data which was collected using Cu Kcx radiation from an
Elliot GX6 rotating anode generator. Data processing was carried out using
established film processing programs (Schwager et al., 1975; Rossmann,
1979). Derivative data sets were scaled to native data using a local scaling
procedure (Matthews and Czerwinski, 1975). Initial heavy atom substitution
models were obtained from difference Patterson maps using vector search
programs (Argos and Rossman, 1974), and were completed by difference
Fourier methods. The final heavy atom model is composed of three sites
for the uranyl acetate derivative, three sites for the platinium iodate derivative
and five sites for the second platinium derivative. Phase refinement and
phase calculation were carried out using the program PHARE (written by
Dr G.Bricogne), with anomalous scattering information used for each
derivative.
From these data, first a multiple isomorphous replacement (Green et al.,
1954) electron density distribution at 4.5 A resolution was calculated. This
clearly showed the outline of the molecule and the large solvent regions
in the crystals. The resolution was then gradually extended to 3.5 A in 45
solvent flattening cycles. From this point onwards, the crystal structure
determination went as follows.
(1) An improved high resolution native dataset became available and the
MIRAS phasing procedure was repeated. Phases could be calculated
to 2.5 A resolution with much improved statistics (Tables III and IV).
(2) A 2.5 A resolution density map was obtained, and subjected to 60
cycles of solvent flattening and phase extension from 3.5 to 2.5 A
resolution by a modification of the method by Frederick et al. (1984).
(3) In the resulting map, the polypeptide chain in the large subunit region
could be traced. A model for this subunit, where side chains were
assigned solely on the basis of the electron density, was refined using
molecular dynamics procedures (Bringer et al., 1987; Fujinaga et al.,
1989). The R factor at this stage was 36%. The resulting partial model
phases (Rice, 1981) were combined with 'solvent flattening phases'
to produce a new 2.25 A electron density map.
(4) The polypeptide chain in the small subunit of MADH was partially
traced in this map and an incomplete model, made up of the large
subunit plus segments of the small subunit, was refined. The R factor
decreased to 30%. Again, phase combination was carried out to produce
an improved electron density map.
(5) In this density a revised model of the entire small subunit of MADH
could now be built, and six disulphide bridges plus the co-factor
unambiguously located. In this step an 'X-ray sequence' for the small
subunit was deduced. The resulting model was subjected to a few cycles
of molecular dynamics refinement. After phase combination a final
2.25-A resolution electron density map was obtained, and used to study
the novel type of co-factor.
Crystals of phenylhydrazine-derivatized enzyme were obtained by, first,
oxidizing the free radical form of the co-factor by soaking in a solution
of Wurster's blue. Afterwards, these oxidized crystals were transferred to
a solution of the phenylhydrazine. The 3.0 A inhibited enzyme dataset was
collected in 10' frames on a FAST area detector system (Arndt, 1982)
using Cu Ka radiation from an Elliot GX2 1 rotating anode X-ray generator
and processed using the MADNES program package (Pflugrath and
Messerschmidt, 1986).
Acknowledgements
We thank Dr P.Colman (CSIRO, Australia) for kindly providing Cca
coordinates for neuraminidase. Professor B.C.Wang (Pittsburgh, USA)
provided an initial version of the programs used for solvent flattening. The
help of Dr G.Vriend and Dr B.W.Dijkstra with graphics and computational
work and of Dr K.S.Wilson for assistance in the use of the Hamburg EMBL
synchrotron radiation facility is gratefully acknowledged. This work was
supported by the Dutch Foundation for Chemical Research (SON), the
BIOSON Research Institute and the Dutch Organization for Scientific
Research (NWO). A grant from the'Werkgroep Gebruik Supercomputers'
for use of the Cyber 205 in Amsterdam is gratefully acknowledged.
2177
F.M.D.Vellieux et al.
References
Argos,P. and Rossmann,M.G. (1974) Acta Crystallogr., A30, 672 -676.
Arndt,U.W. (1982) Nucl. Instrum. Meth., 201, 21-25.
Beer,R.de, Duine,J.A., Frank,J. and Large,P.J. (1980) Biochim. Biophys.
Acta, 662, 370-374.
Brunger,A.T., Kuriyan,J. and Karplus,M. (1987) Science, 235, 458-460.
Buchi,G., Botkin,J.H., Lee,G.C.M. and Yakushijin,K. (1985) J. Am. Chem.
Soc., 107, 5555-5556.
Duine,J.A. and Jongejan,J.A. (1989) Annu. Rev. Biochem., 58, in press.
Duine,J.A., Frank,J. and Jongejan,J.A. (1986) FEMS Microbiol. Rev., 32,
165-178.
Filman,D.J., Bolin,J.T., Matthews,D.A. and Kraut,J. (1982) J. Bio. Chem.,
257, 13663-13672.
Frank,J., Dijkstra,M., Duine,J.A. and Balny,C. (1988) Eur. J. Biochem.,
174, 331-338.
Frederick,C.A., Grable,J., Melia,M., Samudzi,C., Jen-Jacobson,L.,
Wang,B.C., Greene,P., Boyer,H.W. and Rosenberg,J.M. (1984) Nature,
309, 327-331.
Fujinaga,M., Gros,P. and van Gunsteren,W.F. (1989) J. Appl. Cryst., 22,
1-8.
Green,D.W., Ingram,V.M. and Perutz,M.F. (1954) Proc. Roy. Soc., 225,
287-307.
Hartmann,C. and Klinman,J.P. (1988) BioFactors, 1, 41-49.
Houck,D.R., Hanners,J.L. and Unkefer,C.J. (1988) J. Am. Chem. Soc.,
110, 6920-6921.
Husain,M., Davidson,V.L., Gray,K.A. and Knaff,D.B. (1987)
Biochemistry, 26, 4139-4143.
Ishii,Y., Hase,T., Fukumori,Y., Matsubara,H. and Tobari,J. (1983) J.
Biochem. (Tokyo), 93, 107-119.
Karplus,P.A. and Schultz,G.E. (1987) J. Mol. Biol., 195, 701-729.
Kenney,W.C. and McIntire,W. (1983) Biochemistry, 22, 3858-3868.
Kleef,M.A.G. van and Duine,J.A. (1988) FEBS Lett., 237, 91-97.
Lindqvist,Y. and Branden,C.-I. (1985) Proc. Natl. Acad. Sci. USA, 82,
6855-6859.
Lobenstein-Verbeek,C.L., Jongejan,J.A., Frank,J. and Duine,J.A. (1984)
FEBS Lett., 170, 305-309.
Matsumoto,T. and Tobari,J. (1978a) J. Biochem. (Tokyo), 83, 1591-1597.
Matsumoto,T. and Tobari,J. (1978b) J. Biochem. (Tokyo), 84, 461-465.
Matthews,B.W. (1968) J. Mol. Biol., 33, 491-497.
Matthews,B.W. and Czerwinski,E.W. (1975) Acta Crystallogr., A31,
480-487.
McIntire,W.S. and Stults,J.T. (1986) Biochem. Biophys. Res. Commun.,
141, 562-568.
Meer,R.A.van der and Duine,J.A. (1986) Biochem. J., 239, 789-791.
Meer,R.A.van der, Jongejan,J.A. and Duine,J.A. (1987) FEBS Lett., 221,
299-304.
Meer,R.A.van der, Jongegan,J.A. and Duine,J.A. (1988) FEBS Lett., 231,
303 -307.
Pflugrath,J.W. and Messerschmidt,A. (1986) MADNES Users' Guide.
Prince,R.C. (1988) Trends Biochem. Sci., 13, 286-288.
Rice,D.W. (1981) Acta Crystallogr., A37, 491-500.
Rossman,M.G. (1979) J. Appi. Crystallogr., 12, 225-238.
Rossmann,M.G. and Blow,D.M. (1963) Acta Crystallogr., 16, 39-45.
Rossman,M.G., Liljas,A., Branden,C.-I. and Banaszak,L.J. (1975) In
Boyer,P.D. (ed.), The Enzymes. Academic Press, New York, Vol.11, pp.
61 -102.
Schreuder,H.A., van der Laan,J.M., Hol,W.G.J. and Drenth,J. (1988) J.
Mol. Biol., 199, 637-648.
Schwager,P., Bartels,K. and Jones,A. (1975) J. Appi. Crystallogr., 8,
275-280.
Varghese,J.N., Laver,W.G. and Colman,P.W. (1983) Nature, 303, 35-40.
Vellieux,F.M.D., Frank,J., Swarte,M.B.A., Groendijk,H., Duine,J.A.,
Drenth,J. and Hol,W.G.J. (1986) Eur. J. Biochem., 154, 383-386.
Received on March 20, 1989
2178
Các file đính kèm theo tài liệu này:
- j_1460_2075_1989_tb08339_x_4183_2106474.pdf